[Comparison of conditioning regimens containing or no fludarabine in nonmyeloablative allogeneic peripheral blood stem cell transplantation].

作者
Mei Guo,Chang-Lin Yu,Danhong Wang,Jian‐Hui Qiao,Wan-Jun Sun,Bao-fu Shi,Shi Zhang,Qi‐Yun Sun,Bo Yao,Hui‐Sheng Ai
出处
期刊:PubMed [National Institutes of Health]
卷期号:24 (8): 413-5
链接
标识
摘要

OBJECTIVE: To investigate the therapeutic effect of conditioning regimen containing fludarabine in nonmyeloablative allogeneic peripheral blood stem cells transplantation (NAST) in the treatment of hematological diseases. METHODS: Thirty-six patients with acute leukaemia, severe aplastic anaemia, MDS and myelofibrosis received NAST from HLA matched donors' G-CSF mobilized peripheral blood stem cells after nonmyeloabalative conditioning. The conditioning regimen consisted of CTX, Ara-C, CsA, anti-CD(3) antibody or anti-thymocyte globulin and with or without fludarabine. GVHD prophylaxis was performed with cyclosporine combined methotrexate (no MMF group, n = 5) or mycophenolate mofetil (MMF group, n = 31). RESULTS: All of the treatment was generally well tolerated and all cases achieved engrafted of the donor cells. In fludarabine group, engraftment was observed in 87.5% (14/16) patients with complete donor chimerism, graft failure was 12.5% (2/16) and in no fludarabine group, 80% (16/20) and 20% (4/20), respectively. The incidence of acute GVHD (grade I - IV) was 27.8% (10/36) and chronic GVHD 22.2% (8/36). In fludarabine group, grade I - II aGVHD was 37.5%, in no fludarabine group, 20%. cGVHD was 12.5% in fludarabine group and in no fludarabine group 30%, respectively. Interstitial pneumonia (IP) was observed in 16.7% (6/36) of the patients, being 18.7% (3/16) and 15% (3/20) in fludarabine and no fludarabine group, respectively. Overall survival rate was 80.5% (29/36) with a median follow-up of 13 months. CONCLUSIONS: There was no significant difference between fludarabine based (n = 16) and non-fludarabine based conditioning regimen (n = 20) in NAST for the treatment of hematological diseases, regarding for incidence of GVHD, IP, engraftment and survival.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
刚刚
丹亦完成签到,获得积分10
刚刚
大道要熬的应助被科研通管家采纳,获得10
1秒前
在水一方的应助被科研通管家采纳,获得10
2秒前
2秒前
fantasy的应助被科研通管家采纳,获得10
2秒前
2秒前
2秒前
天天快乐的应助被科研通管家采纳,获得10
2秒前
搜集达人的应助被科研通管家采纳,获得10
2秒前
ding的应助被科研通管家采纳,获得10
2秒前
ZeKaWa的应助被科研通管家采纳,获得10
3秒前
ZeKaWa的应助被科研通管家采纳,获得30
3秒前
今后的应助被科研通管家采纳,获得10
3秒前
NexusExplorer的应助被科研通管家采纳,获得10
3秒前
合适的咖啡完成签到,获得积分10
3秒前
无聊的剑心完成签到,获得积分10
3秒前
Lucas的应助被科研通管家采纳,获得10
3秒前
3秒前
尊敬兔子发布了新的文献求助10
4秒前
x甜豆完成签到,获得积分10
5秒前
科研通AI65的应助被尊嘟假嘟采纳,获得10
6秒前
6秒前
黄毛虎发布了新的文献求助80
6秒前
隐形曼青的应助被尊嘟假嘟采纳,获得10
6秒前
徐涛完成签到 ,获得积分10
6秒前
6秒前
科研通AI65的应助被尊嘟假嘟采纳,获得10
6秒前
在水一方的应助被尊嘟假嘟采纳,获得30
6秒前
syvshc的应助被尊嘟假嘟采纳,获得30
7秒前
852的应助被尊嘟假嘟采纳,获得10
7秒前
领导范儿的应助被尊嘟假嘟采纳,获得10
7秒前
万能图书馆的应助被尊嘟假嘟采纳,获得30
7秒前
李爱国的应助被尊嘟假嘟采纳,获得10
7秒前
7秒前
人间慈悲的应助被尊嘟假嘟采纳,获得10
7秒前
jiaqi发布了新的文献求助10
7秒前
隐形听白发布了新的文献求助10
7秒前
8秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8186819
求助须知:如何正确求助?哪些是违规求助? 9575195
关于积分的说明 21839872
捐赠科研通 7784526
什么是DOI,文献DOI怎么找? 3434849
关于科研通互助平台的介绍 2559266
邀请新用户注册赠送积分活动 2481716